UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Modifiers of Cancer Risk in BRCA1 and BRCA2 Mutation Carriers: A Systematic Review and Meta-Analysis

JNCI : Journal of the National Cancer Institute, 2014-06, Vol.106 (6), p.dju091-dju091

2014

Volltextzugriff (PDF)

American Society of Clinical Oncology Policy Statement Update: Genetic and Genomic Testing for Cancer Susceptibility

Journal of clinical oncology, 2015-11, Vol.33 (31), p.3660-3667

2015

Volltextzugriff (PDF)

Update on Genetic Testing in Gynecologic Cancer

Journal of clinical oncology, 2019-09, Vol.37 (27), p.2501-2509

2019

Volltextzugriff (PDF)

BRCA Challenge: BRCA Exchange as a global resource for variants in BRCA1 and BRCA2

PLoS genetics, 2018-12, Vol.14 (12), p.e1007752-e1007752

2018

Volltextzugriff (PDF)

Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial

The Lancet (British edition), 2010-07, Vol.376 (9737), p.235-244

2010

Volltextzugriff (PDF)

BRCA locus-specific loss of heterozygosity in germline BRCA1 and BRCA2 carriers

Nature communications, 2017-08, Vol.8 (1), p.319-11, Article 319

2017

Volltextzugriff (PDF)

Evaluation of ACMG-Guideline-Based Variant Classification of Cancer Susceptibility and Non-Cancer-Associated Genes in Families Affected by Breast Cancer

American journal of human genetics, 2016-05, Vol.98 (5), p.801-817

2016

Volltextzugriff (PDF)

Genomic Signatures Predict the Immunogenicity of BRCA-Deficient Breast Cancer

Clinical cancer research, 2019-07, Vol.25 (14), p.4363-4374

2019

Volltextzugriff (PDF)

Cancer treatment according to BRCA1 and BRCA2 mutations

Nature reviews. Clinical oncology, 2012-09, Vol.9 (9), p.520-528

2012

Volltextzugriff (PDF)

Changes in Cardiovascular Biomarkers With Breast Cancer Therapy and Associations With Cardiac Dysfunction

Journal of the American Heart Association, 2020-01, Vol.9 (2), p.e014708

2020

Volltextzugriff (PDF)

Identification of BRCA1/2 mutation female carriers using circulating microRNA profiles

Nature communications, 2023-06, Vol.14 (1), p.3350-3350, Article 3350

2023

Volltextzugriff (PDF)

Relationship of established risk factors with breast cancer subtypes

Cancer medicine (Malden, MA), 2021-09, Vol.10 (18), p.6456-6467

2021

Volltextzugriff (PDF)

Risk-Reducing Mastectomy in BRCA1 and BRCA2 Mutation Carriers: A Complex Discussion

JAMA : the journal of the American Medical Association, 2019-01, Vol.321 (1), p.27

Domchek, Susan M.

2019

Volltextzugriff (PDF)

Cancer yield of mammography, MR, and US in high-risk women: prospective multi-institution breast cancer screening study

Radiology, 2007-08, Vol.244 (2), p.381-388

2007

Volltextzugriff (PDF)

Risk-Reducing Salpingo-Oophorectomy for the Prevention of BRCA1- and BRCA2-Associated Breast and Gynecologic Cancer: A Multicenter, Prospective Study

Journal of clinical oncology, 2008-03, Vol.26 (8), p.1331-1337

2008

Volltextzugriff (PDF)

Analysis of matched primary and recurrent BRCA1/2 mutation-associated tumors identifies recurrence-specific drivers

Nature communications, 2022-11, Vol.13 (1), p.6728-19, Article 6728

2022

Volltextzugriff (PDF)

Variants at 6q21 implicate PRDM1 in the etiology of therapy-induced second malignancies after Hodgkin's lymphoma

Nature medicine, 2011-08, Vol.17 (8), p.941-943

2011

Volltextzugriff (PDF)

Central nervous system metastases in women who receive trastuzumab‐based therapy for metastatic breast carcinoma

Cancer, 2003-06, Vol.97 (12), p.2972-2977

2003

Volltextzugriff (PDF)

Immunotherapy for Breast Cancer: What Are We Missing?

Clinical cancer research, 2017-06, Vol.23 (11), p.2640-2646

2017

Volltextzugriff (PDF)

Reversion Mutations with Clinical Use of PARP Inhibitors: Many Genes, Many Versions

Cancer discovery, 2017-09, Vol.7 (9), p.937-939

Domchek, Susan M

2017

Volltextzugriff (PDF)

Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation

The New England journal of medicine, 2017-08, Vol.377 (6), p.523-533

2017

Volltextzugriff (PDF)

Risk of metachronous breast cancer after BRCA mutation–associated ovarian cancer

Cancer, 2013-04, Vol.119 (7), p.1344-1348

2013

Volltextzugriff (PDF)

The contribution of pathogenic variants in breast cancer susceptibility genes to familial breast cancer risk

NPJ breast cancer, 2017-06, Vol.3 (1), p.22-10, Article 22

2017

Volltextzugriff (PDF)

Germline genetic testing for breast cancer: which patients? What genes?

Genetics in medicine, 2020-04, Vol.22 (4), p.698-700

Domchek, Susan M.

2020

Volltextzugriff (PDF)

1 – 25 von 416

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(403)
Mit Volltextzugriff
(341)

Publikationsform

Artikel
(414)
Buchkapitel
(2)

Sprache

Englisch
(416)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Modifiers of Cancer Risk in BRCA1 and BRCA2 Mutation Carriers: A Systematic Review and Meta-Analysis

American Society of Clinical Oncology Policy Statement Update: Genetic and Genomic Testing for Cancer Susceptibility

Update on Genetic Testing in Gynecologic Cancer

BRCA Challenge: BRCA Exchange as a global resource for variants in BRCA1 and BRCA2

Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial

BRCA locus-specific loss of heterozygosity in germline BRCA1 and BRCA2 carriers

Evaluation of ACMG-Guideline-Based Variant Classification of Cancer Susceptibility and Non-Cancer-Associated Genes in Families Affected by Breast Cancer

Genomic Signatures Predict the Immunogenicity of BRCA-Deficient Breast Cancer

Cancer treatment according to BRCA1 and BRCA2 mutations

Changes in Cardiovascular Biomarkers With Breast Cancer Therapy and Associations With Cardiac Dysfunction

Identification of BRCA1/2 mutation female carriers using circulating microRNA profiles

Relationship of established risk factors with breast cancer subtypes

Risk-Reducing Mastectomy in BRCA1 and BRCA2 Mutation Carriers: A Complex Discussion

Cancer yield of mammography, MR, and US in high-risk women: prospective multi-institution breast cancer screening study

Risk-Reducing Salpingo-Oophorectomy for the Prevention of BRCA1- and BRCA2-Associated Breast and Gynecologic Cancer: A Multicenter, Prospective Study

Analysis of matched primary and recurrent BRCA1/2 mutation-associated tumors identifies recurrence-specific drivers

Variants at 6q21 implicate PRDM1 in the etiology of therapy-induced second malignancies after Hodgkin's lymphoma

Central nervous system metastases in women who receive trastuzumab‐based therapy for metastatic breast carcinoma

Immunotherapy for Breast Cancer: What Are We Missing?

Reversion Mutations with Clinical Use of PARP Inhibitors: Many Genes, Many Versions

Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation

Risk of metachronous breast cancer after BRCA mutation–associated ovarian cancer

The contribution of pathogenic variants in breast cancer susceptibility genes to familial breast cancer risk

Germline genetic testing for breast cancer: which patients? What genes?

Protocol to evaluate sequential electronic health record-based strategies to increase genetic testing for breast and ovarian cancer risk across diverse patient populations in gynecology practices

Suchergebnisse filtern